γ4/γc/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both γ4 activation function and full dissociation of corepressors

Molecular and Cellular Biology

Volumn 17, Issue 8, 1997, Pages 4259-4271

  Baniahmad, Aria ^a   Thormeyer, Dorit ^a   Renkawitz, Rainer ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; DNA; DNA BINDING PROTEIN; HYBRID PROTEIN; NUCLEAR RECEPTOR CO REPRESSOR 2; NUCLEAR RECEPTOR CO-REPRESSOR 2; REPRESSOR PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPRESSOR GENE; SILENCER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION; YEAST; AMINO ACID SEQUENCE; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING;

ANIMALIA;

AMINO ACID SEQUENCE; DNA; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 0030611781     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.8.4259     Document Type: Article

References (58)

1. Allan, G. F., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1992, Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc. Natl. Acad. Sci. USA 89: 11750-11754.
2. Allan, G. F., E. Lombardi, D. Haynes-Johnson, S. Palmer, M. Kiddoe, P. Kraft, C. Campen, P. Rybczynski, D. W. Combs, and A. Phillips. 1996. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail. Mol. Endocrinol. 10:1206-1213.
3. Baniahmad, A., C. Steiner, A. C. Köhne, and R. Renkawitz. 1990. Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell 61:505-514.
4. Baniahmad, A., A. C. Kühne, and R. Renkawitz. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erb A oncogene product and in the retinoic acid receptor. EMBO J. 11:1015-1023.
5. Baniahmad, A., I. Ha, D. Reinberg, S. Tsai, M.-J. Tsai, and B. W. O'Malley. 1993. Interaction of human thyroid hormone receptor ß with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA 90:8832-8836.
6. Baniahmad, A., M. Eggert, and R. Renkawitz. In A. G. Papavassiliou (ed.), Transcription factors in eucaryotes, in press. Landes Company, CRC Press, Austin. Tex.
7. Baniahmad, A., T. P. Burris, and M.-J. Tsai. 1994. The nuclear hormone receptor superfamily, p. 1-24. In M.-J. Tsai and B. W. O'Malley (ed.), Mechanism of steroid hormone regulation of gene transcription. Landes Company, CRC Press, Austin, Tex.
8. Baniahmad, A., X. Leng, T. P. Burns, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76-86.
9. Barettino, D., M. D.M.V. Ruiz, and H. G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:3039-3049.
10. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
11. Beck-Peccoz, P., V. K. K. Chatterjee, W. W. Chin, L. J. DeGroot, J. L. Jameson, H. Nakamura, S. Refetoff, S. J. Usala, and B. D. Weintraub. 1994. Nomenclature of thyroid hormone receptor ß-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J. Clin. Endocrinol. Metab. 78:990-993.
12. Beekman, J. M., G. F. Allan, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1993. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7:1266-1274.
13. Bhat, M. K., P. McPhie, Y.-T. Ting, Xu-Guang Zhu, and Sheue-yann Cheng. 1995. Structure of the carboxy-terminal region of thyroid hormone nuclear receptors and its possible role in hormone-dependent intermolecular interactions. Biochemistry 34:10591-10599.
14. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375:377-382.
15. Casanova, J., E. Helmer, S. Selmi-Ruby, J.-S. Qi, M. Au-Fliegner, V. Desai-Yajnik, N. Koudinova, F. Yarm, B. M Raaka, and H. H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:5756-5765.
16. Cavailles, V., S. Davois, F. LH̀orset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
17. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
18. Damm, K., C. C. Thompson, and R. M. Evans. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-597.
19. Damm, K., R. A. Heyman, K. Umesong, and R. M. Evans. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA 90:2989-2993.
20. Danielian, P. S., R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025-1033.
21. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element of AF-2 activity. EMBO J. 13:5370-5382.
22. Fondell, J. D., A. L. Roy, and R. G. Roeder. 1993. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev. 7:1400-1410.
23. Fondell, J. D., F. Brunel, K. Hisatake, and R. G. Roeder. 1996. Unliganded thyroid hormone receptor α can target TATA-binding protein for transcriptional repression. Mol. Cell. Biol. 16:281-287.
24. Gerber, H.-P., K. Seipel, O. Georgiev, M. Höfferer, M. Hug, S. Rusconi, and W. Schaffner. 1994. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808-811.
25. Gietz, R. D., and R. A. Woods. 1994. High efficiency transformation with lithium acetate, p. 121-134. In J. R. Johnston (ed.), Molecular genetics of yeast. IRL Press, New York, N.Y.
26. Giniger, E., and M. Ptashne. 1987. Transcription in yeast activated by a putative amphipathic α helix linked to a DNA binding unit. Nature 330:670-672.
27. Greiner, E. F., J. Kirfel, H. Greschik, U. Dörflinger, P. Becker, A. Mercep, and R. Schüle. 1996. Functional analysis of retinoid Z receptor ß, a brain-specific nuclear orphan receptor. Proc. Natl. Acad. Sci. USA 93:10105-10110.
28. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75:791-803.
29. Hörlein, A. J., A. M. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Söderström, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
30. Hörlein, A. J., T. Heinzel, and M. G. Rosenfeld. 1996. Gene regulation by thyroid hormone receptors. Endocrinol. Diabetes 3:412-416.
31. Horwitz, K. B., T. A. Jackson, D. L. Bain, J. K. Richter, G. S. Takimoto, and L. Tung. 1996. Nuclear receptor coactivators and corepressors. Mol . Endocrinol. 10:1167-1177.
32. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
33. Lee, J. W., H.-S. Choi, J. Gyuris, R. Brent, and D. D. Moore. 1995. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9:243-254.
34. Leng, X., S. Y. Tsai, B. W. O'Malley, and M.-J. Tsai. 1993. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic x receptor. J. Steroid Biochem. Mol. Biol. 46:643-661.
35. Leng, X., J. Blanco, S. Y. Tsai, K. Ozato, B. W. O'Malley, and M.-J. Tsai. 1995. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol. 15:255-263.
36. Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:404-408.
37. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
38. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
39. Oñate, S. A., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
40. Parker, M. G., and R. White. 1996. Nuclear receptors spring into action. Nature Struct. Biol. 3:113-115.
41. Renaud, J.-P., N. Rochel, M. Ruff. V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-γ-ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
42. Renkawitz, R. 1990. Transcriptional repression in eukaryotes. Trends Genet. 6:192-197.
43. Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807-3813.
44. Schulman, I. G., C. Li, J. W. R. Schwabe, and R. M. Evans. 1997. The phantom ligand effect: allosteric control of transcription by the retinoic X receptor. Genes Dev. 11:299-308.
45. Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J. 11:4961-4968.
46. Steiner, C., and C. Kaltschmidt. 1989. An automated method for calcium-mediated gene transfer. Trends Genet. 5:138.
47. Sutherland, J. A., A. Cook, A. J. Bannister, and T. Kouzarides. 1992. Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev. 6:1810-1819.
48. Tate, B. F., G. Allenby, R. Janocha, S. Kazmer, J. Speck, L. J. Sturzenbecker, P. Abarzua, A. A. Levin, and J. F. Grippo. 1994. Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor α. Mol. Cell. Biol. 14:2323-2330.
49. Tong, G.-X., M. R. Tanen, and M. K. Bagchi. 1995. Ligand modulates the interaction of thyroid hormone receptor ß with the basal transcription machinery. J. Biol. Chem. 270:10601-10611.
50. Tong, G.-X., M. Jeyakumar, M. R. Tanen, and M. K. Bagchi. 1996. Transcriptional silencing by unliganded thyroid hormone receptor ß requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol. Cell. Biol. 16:1909-1920.
51. Vegeto, E., G. F. Allan, W. T. Schrader, M.-J. Tsai, D. P. McDonnell, and B. W. O'Malley. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713.
52. Voegel, J. J., M. J. S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDA transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667-3675.
53. vom Bauer, E., C. Zechel, D. Heery, M. J. S. Heine, J. M. Garnier, V. Vivat, B. Le Dauarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:110-124.
54. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
55. Wendy, H.-R., and U. Hansen. 1996. Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 12:229-234.
56. Wigler, M., A. Pelicier, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single-copy eukaryotic genes, using total cellular DNA as donor. Cell 14:725-731.
57. Wong, J., Yun-Bo Shi, and A. P. Wolffe. 1995. A role for nucleosome assembly in both silencing and activation of the Xenopus TRβA gene by the thyroid hormone receptor. Genes Dev. 9:2696-2711.
58. Wurtz, J.-M., W. Bourguet, J.-P. Renaud, V. Vivat, P. Chambon, D. Moras, and H. Gronemeyer. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3:87-94.